<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药筛 | wechat-feeds</title><link>http://Mzg5NTI5ODYzOA.favicon.privacyhide.com/favicon.ico</link><description>药品筛选</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 03 Mar 2021 21:09:31 +0800</pubDate><image><url>http://Mzg5NTI5ODYzOA.favicon.privacyhide.com/favicon.ico</url><title>药筛 | wechat-feeds</title><link>http://Mzg5NTI5ODYzOA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>艾力斯重磅一类新药伏美替尼获批，进军百亿市场</title><link>https://mp.weixin.qq.com/s/pRWu69SWQZAijeBCudg0SQ</link><description></description><content:encoded><![CDATA[艾力斯重磅一类新药伏美替尼获批，进军百亿市场]]></content:encoded><pubDate>Wed, 03 Mar 2021 17:34:23 +0800</pubDate></item><item><title>好政策，不亏待老实人</title><link>https://mp.weixin.qq.com/s/k529LbejTkpryBqDdu9Ngg</link><description></description><content:encoded><![CDATA[好政策，不亏待老实人]]></content:encoded><pubDate>Tue, 02 Mar 2021 18:31:47 +0800</pubDate></item><item><title>广东嘉博 丙泊酚中/长链脂肪乳过评价 | 上周仿制药动态（2.22-2.28）</title><link>https://mp.weixin.qq.com/s/n_RPabVQGIV_IroxOi2a9Q</link><description></description><content:encoded><![CDATA[广东嘉博 丙泊酚中/长链脂肪乳过评价 | 上周仿制药动态（2.22-2.28）]]></content:encoded><pubDate>Mon, 01 Mar 2021 18:58:15 +0800</pubDate></item><item><title>仅用5天，2新冠疫苗获批，国内已累计4款</title><link>https://mp.weixin.qq.com/s/4_LJpWmSUkble3MSPQ9KbQ</link><description></description><content:encoded><![CDATA[仅用5天，2新冠疫苗获批，国内已累计4款]]></content:encoded><pubDate>Thu, 25 Feb 2021 22:10:55 +0800</pubDate></item><item><title>中药注射剂，大势已去？</title><link>https://mp.weixin.qq.com/s/ILQAsBXATGBuyff-yJqWJA</link><description></description><content:encoded><![CDATA[中药注射剂，大势已去？]]></content:encoded><pubDate>Tue, 23 Feb 2021 19:15:46 +0800</pubDate></item><item><title>南京海纳 奥美拉唑碳酸氢钠干混悬首仿上市 | 上周仿制药动态（2.8-2.21）</title><link>https://mp.weixin.qq.com/s/ApWDye8p_e2FsraZmWnFBQ</link><description></description><content:encoded><![CDATA[南京海纳 奥美拉唑碳酸氢钠干混悬首仿上市 | 上周仿制药动态（2.8-2.21）]]></content:encoded><pubDate>Mon, 22 Feb 2021 14:52:59 +0800</pubDate></item><item><title>数据分享：4个重磅生物药，国产快速上量</title><link>https://mp.weixin.qq.com/s/Myzjt8b4-lDWUpUKDYNdlg</link><description></description><content:encoded><![CDATA[数据分享：4个重磅生物药，国产快速上量]]></content:encoded><pubDate>Fri, 19 Feb 2021 20:15:26 +0800</pubDate></item><item><title>大筛祝您新年快乐，感谢一路相伴！</title><link>https://mp.weixin.qq.com/s/ippY1GI4jVe8fe5rWkBPSQ</link><description></description><content:encoded><![CDATA[大筛祝您新年快乐，感谢一路相伴！]]></content:encoded><pubDate>Thu, 11 Feb 2021 17:06:34 +0800</pubDate></item><item><title>合肥兆科 磺达肝癸首家通过一致性评价 | 上周仿制药动态（2.1-2.7）</title><link>https://mp.weixin.qq.com/s/lGTbQszV3-1zDYcII60_Tw</link><description></description><content:encoded><![CDATA[合肥兆科 磺达肝癸首家通过一致性评价 | 上周仿制药动态（2.1-2.7）]]></content:encoded><pubDate>Mon, 08 Feb 2021 18:52:36 +0800</pubDate></item><item><title>江苏公布第一轮带量采购结果，价格是个迷</title><link>https://mp.weixin.qq.com/s/3DBxM74zFMQQzT8Wk7TP5Q</link><description></description><content:encoded><![CDATA[江苏公布第一轮带量采购结果，价格是个迷]]></content:encoded><pubDate>Fri, 05 Feb 2021 19:01:26 +0800</pubDate></item></channel></rss>